Personal Protective Equipment for Infection Control Market Report 2025

The personal protective equipment for infection control market size has grown strongly in recent years. It will grow from $25.1 billion in 2024 to $26.64 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth during the historic period can be attributed to rising concerns over nosocomial infections, the implementation of stricter workplace safety regulations, expansion of healthcare infrastructure, increasing surgical volumes, government stockpiling initiatives, and the growth of medical tourism.

The personal protective equipment for infection control market size is expected to see strong growth in the next few years. It will grow to $33.43 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth during the forecast period can be attributed to an aging global population, the expansion of telehealth and home healthcare services, improved infection control protocols, growth in ambulatory surgical centers, and increased investments in public health. Major trends in the forecast period include the development of smart personal protective equipment, technological innovations in PPE materials, advances in infection control technologies, improvements in filtration technologies, and integration with telehealth and IoT platforms.

The rising incidence of infectious diseases is expected to drive the growth of the personal protective equipment (PPE) for infection control market in the coming years. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites and can spread directly or indirectly from person to person or from animals or the environment to humans. The increase in infectious disease cases is largely due to the preference for crowded urban living and the rise in global travel, both of which accelerate disease transmission. Personal protective equipment for infection control helps reduce the spread of infectious diseases by creating a physical barrier that prevents healthcare workers and individuals from coming into direct contact with infectious agents. For example, in March 2025, a report by the UK Health Security Agency, a UK government department, indicated that in England, between 2023 and 2024, hospital admission rates for infectious diseases and infections were nearly twice as high among people living in the most deprived 20% of areas compared to those in the least deprived areas. Additionally, in February 2024, GOV.UK reported that tuberculosis (TB) cases in England increased from 4,380 in 2022 to 4,850 in 2023, marking a 10.7% rise. Therefore, the growing incidence of infectious diseases is driving the expansion of the personal protective equipment for infection control market.

Leading companies in the personal protective equipment for infection control market are focusing on developing innovative products such as next-generation personal protective shields to improve user safety, comfort, and protection against airborne pathogens. Next-generation personal protective shields are advanced face and body protection devices designed with better materials, ergonomic features, and enhanced protective capabilities to offer superior defense against infectious agents. For instance, in March 2025, Stryker Corporation, a US-based medical technology firm, introduced the Steri-Shield 8 personal protection system, a next-generation PPE solution designed for healthcare professionals. This system includes a customizable helmet with three points of contact for a secure, adjustable fit and features a unique ponytail path to accommodate long-haired users. It provides improved visibility with a 22% wider field of vision and a brighter helmet light, as well as a redesigned fan system that cools both the front and back of the neck for greater comfort. The system offers three toga styles that deliver AAMI level 4 (2012) protection, ensuring the highest level of fluid and microbial barrier. Additionally, it includes a slimmer battery and a more efficient charging station, reflecting Stryker’s dedication to innovation and user-focused design in PPE.

In July 2024, Ansell Limited, an Australia-based company specializing in personal protective equipment, acquired the PPE business of Kimberly-Clark Corporation for $640 million. Through this acquisition, Ansell aims to broaden its portfolio of infection control and industrial safety solutions by incorporating Kimberly-Clark’s Kimtech and KleenGuard brands, along with sustainable PPE disposal and contamination control programs. Kimberly-Clark Corporation is a US-based company offering various products, including fluid-resistant face masks, surgical masks, isolation gowns, and disposable gloves.

Major players in the personal protective equipment for infection control market are Cardinal Health Inc., Honeywell International Inc., 3M Company, Kimberly-Clark Corporation, Stryker Corporation, DuPont de Nemours Inc., STERIS plc, ELIS UK Limited, Ansell Limited, SHOWA Group, SAS Safety Corp., Moldex-Metric Inc., Uvex Arbeitsschutz GmbH, MEC Industries Inc., Alpha Pro Tech Ltd., Polyco Healthline Ltd., Berner International GmbH, Gateway Safety Inc., Plasti Surge Industries Pvt. Ltd., Phillips Safety Products Inc., Franz Mensch GmbH, Univet S.p.A., Dastex Reinraumzubehör GmbH & Co. KG.

North America was the largest region in the personal protective equipment for infection control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in personal protective equipment for infection control report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the personal protective equipment for infection control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personal protective equipment for infection control market consists of sales of surgical masks, shoe covers, hand sanitizers, and face shields. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The personal protective equipment for infection control market research report is one of a series of new reports that provides personal protective equipment for infection control market statistics, including personal protective equipment for infection control industry global market size, regional shares, competitors with a personal protective equipment for infection control market share, detailed personal protective equipment for infection control market segments, market trends and opportunities, and any further data you may need to thrive in the personal protective equipment for infection control industry. This personal protective equipment for infection control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Personal protective equipment (PPE) for infection control consists of specialized clothing and devices worn by healthcare workers and others to form a protective barrier against exposure to infectious pathogens and hazardous biological materials. This equipment is crucial for preventing infection transmission by minimizing direct contact with contaminants and airborne particles in medical and other high-risk environments.

The main types of products in personal protective equipment for infection control include gloves, face masks, gowns and coveralls, eye protection, and respirators. Gloves are protective coverings for the hands made from various materials such as latex or nitrile, designed to prevent direct contact with infectious agents. They come in different material types including latex, nitrile, polyethylene, polypropylene, and other advanced materials, and are distributed through channels like direct sales, online retail, traditional retail, catalog sales, wholesalers, and distributors. These products are applied in infection prevention, occupational safety, emergency response, aerosol transmission protection, and healthcare settings, and are utilized by end users such as hospitals, ambulatory surgical centers, pharmacies, diagnostic laboratories, and public health institutions.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.